Methods of screening using a natriuretic peptide receptor

Details Methods of screening using a natriuretic peptide receptor Methods of screening using a natriuretic peptide receptor

2011-05-17

2011-05-17

Bunner, Bridget E (Department: 1647)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S007100, C435S007200, C435S007210, C435S008000, C530S350000, C800S003000

Reexamination Certificate

active

07943296

ABSTRACT:
This disclosure provides an intracellular fragment of natriuretic peptide receptor A (NPRA), referred to herein as soluble natriuretic peptide receptor-related fragment (sNRF). It is shown herein that sNRF causes NP resistance. Based on these observations, methods of treating a cardiovascular disorder by inhibiting the activity of sNRF are disclosed. Assays are provided that use sNRF to screen agents for their ability to increase the biological activity of an NPR, for example agents that increase the sensitivity of NPR for NPs (such as atrial natriuretic peptide, ANP), or that decrease growth factor deleterious effects, or combinations thereof. Also provided are agents identified using the disclosed assays, and methods of using the agents, for example to treat or diagnose a cardiovascular disorder, such as heart failure.

REFERENCES:
patent: 2005/0113286 (2005-05-01), Schreiner et al.
patent: 2005/0272650 (2005-12-01), Mohapatra
patent: 2008/0214437 (2008-09-01), Mohapatra et al.
Potter et al. Natriuretic peptides: their stuctures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 191):341-366, 2009.
Fujio et al. Regulation of natriuretic peptide receptor A and B expression by transforming growth factor-beta1 cultured aortic smooth muscle cells. Hypertension 23: 908-913, 1994.
Kaupp et al. Cyclic nucleotide-gated ion channels. Physiol Rev 82: 769-824, 2002.
Matulef et al. Cyclic nucleotide-gated ion channels. Annu Rev Cell Dev Biol 19: 23-44, 2003.
Airhart et al. Soluble natriuretic peptide receptor-related fragment (sNRF), an alternative product of the natriuretic peptide receptor gene, regulates receptor function. Circulation 114: II, 666, abstract 3152; 2006).
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotech 18(1): 34-39, 2000.
Bork, A. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res 10: 398-400, 2000.
Doerks et al. Protein annotation: detective work for function prediction. Trends in Genetics 14(6): 248-250, 1998.
Smith et al. The challenges of genome sequence annotation or “The devil is in the details”. Nature Biotech 15: 1222-1223, 1997.
Brenner, S.E. Errors in genome function. Trends in Genetics 15(4): 132-133, 1999.
Bork et al. Go hunting in sequence databases but watch out for the traps. Trends in Genetics. 12(10): 425-427, 1996.
Wells. J.A. Additivity of mutational effects in proteins. Biochemistry 29 (37): 8509-8517, 1990.
Ngo et al. Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994.
Accession No. NP—000897, Oct. 18, 2005.
Airhart et al., “Atrial Natriuretic Peptide Induces Natriurectic Peptide Receptor-cGMP-Dependent Protein Kinase Interaction,”J. Biol. Chem. 278:38693-38698, 2003.
Cogan et al., “Plasticity of Vascular Smooth Muscle α-Actin Gene Transcription,”J. Biol. Chem. 270:11310-11321, 1995.
Crooke, “Antisense Oligonucleotides as Therapeutics for Hyperlipidaemias,”Expert Opin. Biol. Ther. 5:907-917, 2005.
Fan et al., “Down-Regulation Does not Mediate Natriuretic Peptide-Dependent Desensitization of a Natriuretic Peptide Receptor (NPR)-A or NPR-B: Guanylyl Cyclase-Linked Natriuretic Peptide Receptors Do Not Internalize,”Mol. Pharmacol. 67:174-183, 2005.
Gunawardena, “Multisite Protein Phosphorylation Makes a Good Threshold but can be a Poor Switch,”Proc. Natl. Acad. Sci. USA 102:14617-14622, 2005.
Johnson et al., “Identification and Validation of the Mitochondrial F1F0-ATPase as the Molecular Target of the Immunomodulatory Benzodiazepine Bz-423,”Chem. Biol. 12:485-496, 2005.
Mucke, “Cardiovascular and Renal Developments: Patent Highlights Jan. to Jun. 2006,”Curr. Opin. Invest. Drugs 7:792-798, 2006.
Patel et al., “Cardiac-Specific Attenuation of a Natriuretic Peptide A Receptor Activity Accentuates Adverse Cardiac Remodeling and Mortality in Response to Pressure Overload,”Am. J. Physiol. Hear Circ. Physiol. 289:H777-H784, 2005.
Piggott et al., “Natriuretic Peptides and Nitric Oxide Stimulate cGMP Synthesis in Different Cellular Compartments,”J. Gen. Physiol. 128:3-14, 2006.
Potter and Hunter, “Guanylyl Cyclase-Linked Natriuretic Peptide Receptors: Structure and Regulation,”J. Biol. Chem. 276:6057-6060, 2001.
Silberbach and Roberts, “Natriuretic Peptide Signalling Molecular and Cellular Pathways to Growth Regulation,”Cell. Signal. 13:221-231, 2001.
Thompson and Garbers, “Dominant Negative Mutations of the Guanylyl Cyclase-A Receptor,”J. Biol. Chem. 270:425-430, 1995.
Wang et al., “AAV Delivery of Mineralocorticoid Receptor shRNA Prevents Progression of Cold-Induced Hypertension and Attenuates Renal Damage,”Gene Ther. 13:1097-1103, 2006.

Affiliated with

Also associated with

Rating

Methods of screening using a natriuretic peptide receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of screening using a natriuretic peptide receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of screening using a natriuretic peptide receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2685929